Also categorized in Global Health:
To Battle Opioid Crisis, Some Track Overdoses in Real Time
x hide permanently

Patients with Rheumatic Disease Are Protecting Themselves from COVID-19—But At What Cost?

Latest Medical Industry News

Photo: Pixabay

Patients with chronic rheumatic diseases (CRD) had a much lower seroprevalence of SARS-CoV-2 antibodies compared to blood donors, but had higher rates of depression, increased pain, and decreased exercise, according to a study.

“Patients with CRD, such as Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA), require special attention during the COVID-19 pandemic, as they are considered at risk of severe infections. We assessed the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in patients with SLE and RA and patient behavior, disease-related symptoms, and mental health,” the study authors stated.

They evaluated 405 ...